Vor Biopharma Inc (VOR)
1.81
+0.01
(+0.56%)
USD |
NASDAQ |
May 17, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Price to Book Value: 1.004 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.004 |
| May 16, 2024 | 0.9986 |
| May 15, 2024 | 0.9653 |
| May 14, 2024 | 0.9321 |
| May 13, 2024 | 0.9432 |
| May 10, 2024 | 0.9487 |
| May 09, 2024 | 1.004 |
| May 08, 2024 | 1.026 |
| May 07, 2024 | 0.9764 |
| May 06, 2024 | 0.9709 |
| May 03, 2024 | 0.9986 |
| May 02, 2024 | 0.9758 |
| May 01, 2024 | 0.9814 |
| April 30, 2024 | 0.9536 |
| April 29, 2024 | 0.9647 |
| April 26, 2024 | 0.937 |
| April 25, 2024 | 0.9426 |
| April 24, 2024 | 0.9647 |
| April 23, 2024 | 1.042 |
| April 22, 2024 | 1.009 |
| April 19, 2024 | 0.9481 |
| April 18, 2024 | 0.9315 |
| April 17, 2024 | 0.9592 |
| April 16, 2024 | 0.9481 |
| April 15, 2024 | 0.998 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.053 |
| April 11, 2024 | 1.131 |
| April 10, 2024 | 1.092 |
| April 09, 2024 | 1.159 |
| April 08, 2024 | 1.214 |
| April 05, 2024 | 1.198 |
| April 04, 2024 | 1.153 |
| April 03, 2024 | 1.164 |
| April 02, 2024 | 1.159 |
| April 01, 2024 | 1.220 |
| March 28, 2024 | 1.073 |
| March 27, 2024 | 1.000 |
| March 26, 2024 | 0.9776 |
| March 25, 2024 | 0.9226 |
| March 22, 2024 | 0.8729 |
| March 21, 2024 | 0.8865 |
| March 20, 2024 | 0.8141 |
| March 19, 2024 | 0.8231 |
| March 18, 2024 | 0.8684 |
| March 15, 2024 | 0.8729 |
| March 14, 2024 | 0.8311 |
| March 13, 2024 | 0.9054 |
| March 12, 2024 | 0.9054 |
| March 11, 2024 | 0.9459 |
| March 08, 2024 | 1.054 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6419
Minimum
Nov 01 2023
5.931
Maximum
Mar 31 2021
1.520
Average
1.169
Median
May 02 2023
Price to Book Value Benchmarks
| Masimo Corp | 4.826 |
| AnaptysBio Inc | 14.33 |
| Apellis Pharmaceuticals Inc | 18.80 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
Price to Book Value Related Metrics
| Price | 1.81 |
| Earnings Yield | -97.79% |
| Market Cap | 123.55M |